EUDA Health Holdings Files 6-K on Gilandi Limited Engagement

TL;DR

**EUDA Health just filed a 6-K about Gilandi Limited, signaling a potentially big deal.**

AI Summary

EUDA Health Holdings Limited (EUDA) filed a 6-K on January 23, 2024, indicating a significant development with Gilandi Limited, a British Virgin Islands company. This filing, for the month of January 2024, signals a potential material event that could impact EUDA's operations or financial structure. Investors should pay close attention to the details of EUDA's engagement with Gilandi Limited, as it could lead to changes in the company's strategic direction or asset base, directly affecting the stock's future valuation.

Why It Matters

This filing signals a new, potentially significant relationship or transaction between EUDA Health Holdings and Gilandi Limited, which could alter EUDA's business prospects or financial health. Investors need to understand the nature of this engagement to assess its impact on the company's future performance.

Risk Assessment

Risk Level: medium — The filing mentions a new entity, Gilandi Limited, without specifying the nature of the engagement, introducing uncertainty and potential for both positive and negative outcomes.

Analyst Insight

A smart investor would monitor subsequent filings from EUDA Health Holdings Limited closely for specific details regarding the nature and financial implications of the engagement with Gilandi Limited to assess its impact on the company's valuation.

Key Players & Entities

• EUDA Health Holdings Limited (company) — the registrant filing the 6-K
• Gilandi Limited (company) — a British Virgin Islands company mentioned in the filing
• January 2024 (date) — the month for which the report is filed
• January 16, 2024 (date) — the date of the event involving EUDA and Gilandi Limited
• 001-40678 (other) — Commission File Number for EUDA Health Holdings Limited

Forward-Looking Statements

• Further details regarding the nature of the engagement between EUDA Health Holdings Limited and Gilandi Limited will be disclosed in subsequent filings. (EUDA Health Holdings Limited) — high confidence, target: Q1 2024
• The engagement with Gilandi Limited could involve a strategic partnership, acquisition, or a significant transaction. (EUDA Health Holdings Limited) — medium confidence, target: Q2 2024

FAQ

Key Financial Figures

• $500,000 — ertible loan in the principal amount of $500,000 to be paid in two (2) tranches of $250,
• $250,000 — 0,000 to be paid in two (2) tranches of $250,000 each by January 31, 2024 and March 31,
• $1.00 — the Company’s ordinary shares at $1.00 per share. On January 17, 2024, the Com

Filing Documents

• form6-k.htm (6-K) — 18KB
• ex10-1.htm (EX-10.1) — 76KB
• 0001493152-24-003350.txt ( ) — 95KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: January 22, 2024 EUDA Health Holdings Limited By: /s/ Wei Wen Kelvin Chen Name: Wei Wen Kelvin Chen Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR